Orgenesis up after PE firm injects $50 mln into unit
07/11/2022 15:23
** Shares of biotech firm Orgenesis Inc ORGS.O up ~1% at
$1.40
** Co secures $50 mln investment for unit Morgenesis LLC
from private equity firm Metalmark Capital Partners
** Investment gives Morgenesis a pre-money valuation of $125
mln, subject to certain adjustments, ORGS says
** Metalmark to pay $30 mln upfront and two future payments
of $10 mln each if certain targets are met
** YTD ORGS has lost over half of its market capitalization
(Reporting by Niket Nishant in Bengaluru)
((Niket.Nishant@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules